Tradipitant

Generic Name
Tradipitant
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C28H16ClF6N5O
CAS Number
622370-35-8
Unique Ingredient Identifier
NY0COC51FI
Background

Tradipitant has been used in trials studying the treatment and prevention of Eczema, Pruritus, Gastroparesis, Chronic Pruritus, and Atopic Dermatitis, among others.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Phase 3
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Tradipitant
Drug: Placebo
First Posted Date
2018-06-26
Last Posted Date
2024-05-13
Lead Sponsor
Vanda Pharmaceuticals
Target Recruit Count
375
Registration Number
NCT03568331
Locations
🇺🇸

Vanda Investigational Site, Spokane, Washington, United States

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Tradipitant
Drug: Placebo
First Posted Date
2016-01-11
Last Posted Date
2024-06-13
Lead Sponsor
Vanda Pharmaceuticals
Target Recruit Count
168
Registration Number
NCT02651714
Locations
🇺🇸

Vanda Investigational Site, Spokane, Washington, United States

Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: tradipitant
Drug: Midazolam
First Posted Date
2015-12-03
Last Posted Date
2016-04-27
Lead Sponsor
Vanda Pharmaceuticals
Target Recruit Count
24
Registration Number
NCT02621385
Locations
🇨🇭

Vanda Investigational Site, Arzo, Switzerland

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy